Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienjoy Holding (SJ) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Scienjoy Holding (SJ) over the last 8 years, with Q3 2025 value amounting to $254.1 billion.

  • Scienjoy Holding's Cash & Equivalents rose 1692.15% to $254.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $254.1 billion, marking a year-over-year increase of 1692.15%. This contributed to the annual value of $252.5 billion for FY2024, which is 2291.14% up from last year.
  • Scienjoy Holding's Cash & Equivalents amounted to $254.1 billion in Q3 2025, which was up 1692.15% from $41.3 million recorded in Q2 2025.
  • In the past 5 years, Scienjoy Holding's Cash & Equivalents registered a high of $291.9 billion during Q3 2021, and its lowest value of $24.6 million during Q4 2022.
  • Over the past 5 years, Scienjoy Holding's median Cash & Equivalents value was $37.7 million (recorded in 2021), while the average stood at $99.0 billion.
  • As far as peak fluctuations go, Scienjoy Holding's Cash & Equivalents soared by 2659206339206.35% in 2021, and later plummeted by 9998.79% in 2022.
  • Quarter analysis of 5 years shows Scienjoy Holding's Cash & Equivalents stood at $37.7 million in 2021, then crashed by 34.6% to $24.6 million in 2022, then increased by 15.78% to $28.5 million in 2023, then rose by 23.2% to $35.2 million in 2024, then soared by 722592.88% to $254.1 billion in 2025.
  • Its Cash & Equivalents stands at $254.1 billion for Q3 2025, versus $41.3 million for Q2 2025 and $286.5 billion for Q1 2025.